The Dengue Vaccine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Dengue Vaccine Market?
In the Dengue Vaccine Global Market Report, the market size has seen significant growth recently. It is projected to increase from $0.64 billion in 2024 to $0.72 billion in 2025. The compound annual growth rate (CAGR) during this period is expected to be 12.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Dengue Vaccine Industry?
The Dengue Vaccine Global Market is predicted to expand to a size of $1.14 billion in 2029, with a compound annual growth rate (CAGR) of 12.3%.
Download Your Free Sample of the 2025 Dengue Vaccine Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Dengue Vaccine Market?
The key drivers in the dengue vaccine market are:
• Increased incidence of dengue disease
• Growing initiatives by multiple organizations
• Rise in clinical trials for vaccine development
• Increased focus on multi-strain and tetravalent vaccine formulations
Global Market Segmentation: Identifying Major Dengue Vaccine Industry Segments
The dengue vaccinemarket covered in this report is segmented –
1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine
2) By Vaccine Phase: Phase I, Phase II, Phase III
3) By Treatment: Diuretic, Anti-Allergic, Blood Thinners, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users
Pre-order the 2025 Dengue Vaccine Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Dengue Vaccine Market?
The key trends in the dengue vaccine market are:
• The increasing preventive vaccines demand is an emerging trend in the dengue vaccine market.
• Advancements in vaccine technology are shaping the future of the global dengue vaccine market.
• The development of combination vaccines is an upcoming significant trend in the market.
• The rise in research and clinical trials for new vaccine candidates and focus on improving vaccine efficacy and safety profiles are key trends shaping the market.
Who Are the Top Competitors & Leading Players in the Dengue Vaccine Market?
Major companies in the dengue vaccine market are:
• Merck & Co. Inc.
• Sanofi Pasteur Limited
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company
• Sun Pharmaceutical Industries Ltd.
• Biological E. Limited
• Saint Louis University
• Indian Immunologicals Limited
• Serum Institute of India Pvt. Ltd.
• Bavarian Nordic
• Instituto Butantan
• Bharat Biotech Ltd.
• Panacea Biotec Limited
• SABIN Vaccine Institute
• Medigen Vaccine Biologics Corporation
• Emergex Vaccines Holding Ltd.
• BioNet-Asia Co. Ltd.
• Codagenix Inc.
• KM Biologics Co. Ltd.
• Chula Vaccine Research Center
• Imutex Ltd.
Regional Dominance: Which Area Leads the Global Dengue Vaccine Market?
Asia-Pacific was the largest region in the dengue vaccine market in 2024
